Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.2.0.727
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2015
Summary Of Significant Accounting Policies Tables  
Schedule of Concentration of Revenue and Geographic Area
For the Three Months Ended June 30, 2015     For the Three Months Ended June 30, 2014  
Licensor   License Amount     % of Revenue     Licensor   License Amount     % of Revenue  
Sarif Biomedical LLC   $ 325,000       24 %   CRFD Research, Inc.   $ 2,800,000       73 %
Selene Communication Technologies, LLC   $ 150,000       11 %   IP Liquidity Ventures, LLC   $ 937,500       24 %
E2E Processing, Inc.   $ 140,000       10 %   Selene Communication Technologies, LLC   $ 75,000       2 %
MedTech GmbH   $ 131,420       9 %   Vantage Point Technology, Inc.   $ 11,000       0 %
E2E Processing, Inc.   $ 120,000       9 %   CyberFone Systems, LLC   $ 1,000       0 %
                                     
    Total       63 %       Total       100 %
Schedule of Basic and Diluted Loss Per Share
    For the Three Months Ended June 30, 2015     For the Three Months Ended June 30, 2014     For the Six Months Ended June 30, 2015     For the Six Months Ended June 30, 2014  
Net loss     (4,502,696 )   $ (1,589,743 )     (9,284,267 )   $ (1,870,355 )
                                 
Denominator                                
Denomintor for basic and diluted loss per share                          
(weighted-average shares)     13,998,563       11,016,646       13,937,872       10,980,290  
                                 
Earnings (Loss) per common share, basic and diluted:                          
Income (Loss)   $ (0.32 )   $ (0.14 )   $ (0.67 )   $ (0.17 )